Houston Methodist DeBakey Heart and Vascular Center


 

Cardiovascular and Renal Outcomes With Efpeglenatide in Type 2 Diabetes: AMPLITUDE-O Trial

100 views
October 20, 2021
Comments 0
Login to view comments. Click here to Login